Angels Unawares

FDA Approves First Cellular Therapy to Treat Patients with Type 1 Diabetes

Retrieved on: 
Wednesday, June 28, 2023
Vaccine, China Biologic Products, Seizure, Injection, Insulin, Hyperglycemia, Angels Unawares, Education, Diabetes, Diarrhea, Office of Inspector General, U.S. Department of Health and Human Services, Human services, Public, Center for Biologics Evaluation and Research, Food, Cosmetics, Multimedia, Abdominal pain, Animal, Fatigue, Blood, Hypoglycemia, Dietary supplement, Patient, Anemia, Nausea, Heated tobacco product, Research, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Consciousness, Safety, Injury, Medical device, Pharmaceutical industry

"Today's approval, the first-ever cell therapy to treat patients with type 1 diabetes, provides individuals living with type 1 diabetes and recurrent severe hypoglycemia an additional treatment option to help achieve target blood glucose levels."

Key Points: 
  • "Today's approval, the first-ever cell therapy to treat patients with type 1 diabetes, provides individuals living with type 1 diabetes and recurrent severe hypoglycemia an additional treatment option to help achieve target blood glucose levels."
  • People with type 1 diabetes also perform blood glucose checks several times a day to guide the management of their diabetes.
  • Some people with type 1 diabetes have trouble managing the amount of insulin needed every day to prevent hyperglycemia (high blood sugar) without causing hypoglycemia.
  • Lantidra is approved with patient-directed labeling to inform patients with type 1 diabetes about benefits and risks of Lantidra.

Ridiculous Excuses Not to Be Inclusive

Retrieved on: 
Wednesday, March 15, 2023
Caregiver, Convention on the Rights of Persons with Disabilities, WDSD, Education, National Down Syndrome Society, Exercise, National Coordinator for Change, Life, Organization, Ableism, Friends, Disability, Down's Syndrome Association, Culture, System, Intellectual, Freedom, Down syndrome, United Nations Convention Against Corruption, Partnership, Indiana Production, Communication, World Down Syndrome Day, Sport, Parent, Trisomy, Best Buddies International, Taboo, Cell, Angels Unawares, Creativity, Nintendo DSi, SMALL, Cannes Lions International Festival of Creativity, Knowledge, United Nations Convention, Light, Person, Public policy, Human, London International Festival of Theatre, UN, Music, Workplace, Down, Client, Consumer electronics, Nightclub, Entertainment, Insurance, Residential care, TikTok

To mark the occasion, CoorDown presents RIDICULOUS EXCUSES NOT TO BE INCLUSIVE, the international awareness campaign created in collaboration with SMALL NY and TikTok.

Key Points: 
  • To mark the occasion, CoorDown presents RIDICULOUS EXCUSES NOT TO BE INCLUSIVE, the international awareness campaign created in collaboration with SMALL NY and TikTok.
  • WATCH VIDEO
    In a world increasingly focused on inclusion, there are still those who roll out ridiculous excuses not to be inclusive.
  • Some of these excuses were so incredibly ridiculous that they deserved to be brought to life and properly celebrated.
  • These are some of the ridiculous excuses given, excuses that deny people who have Down syndrome the chance to fully participate.

The American Society for Preventive Cardiology Publishes Clinical Practice Statement on Improving the Enrollment of Women and Racially/Ethnically Diverse Populations in Cardiovascular Clinical Trials

Retrieved on: 
Tuesday, October 26, 2021
Woman, Death, Research, CV, CVD, NIH, Organization, Cardiovascular disease, Policy, Degenerative disease, Review, American Journal, Epidemiology, Clinical Practice, Literature, Multimedia, Man, Fear, Angels Unawares, Risk, ASPC, Population, Fortis Healthcare, Education, Society, Medical imaging, Medical device, Pharmaceutical industry

JACKSONVILLE, Fla., Oct. 26, 2021 /PRNewswire/ -- The American Society for Preventive Cardiology (ASPC) has recently published a Clinical Practice Statement in the American Journal of Preventive Cardiology: Improving the Enrollment of Women and Racially/Ethnically Diverse Populations in Cardiovascular Clinical Trials.

Key Points: 
  • JACKSONVILLE, Fla., Oct. 26, 2021 /PRNewswire/ -- The American Society for Preventive Cardiology (ASPC) has recently published a Clinical Practice Statement in the American Journal of Preventive Cardiology: Improving the Enrollment of Women and Racially/Ethnically Diverse Populations in Cardiovascular Clinical Trials.
  • Based on this review of the literature, both women and racially/ethnically diverse populations continue to be underrepresented in cardiovascular (CV) clinical trials.
  • Diverse representation for clinical trials in CV drugs is vital for clinicians and researchers to be assured that the data reflects the diverse U.S. population.
  • For more information visit: https://www.aspconline.org/
    Published quarterly, TheAmerican Journal of Preventive Cardiologyis the official journal theAmerican Society for Preventive Cardiology.